Serial blood serum measurements of calprotectin and deoxyribonuclease in COVID-19 patients during hospitalization and recovery until one year: a prospective, multicenter, observational study.

Saved in:
Bibliographic Details
Title: Serial blood serum measurements of calprotectin and deoxyribonuclease in COVID-19 patients during hospitalization and recovery until one year: a prospective, multicenter, observational study.
Authors: Kildal AB; Anesthesia and Critical Care Research Group, Department of Clinical Medicine, Faculty of Health Sciences, UIT - The Arctic University of Norway, Tromsø, 9019, Norway. anders.kildal@uit.no.; Department of Anesthesiology and Intensive Care, University Hospital of North Norway, Tromsø, 9019, Norway. anders.kildal@uit.no., Ueland T; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, 0424, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, 0315, Norway.; Thrombosis Research Center (TREC), Division of internal medicine, University hospital of North Norway, Tromsø, 9019, Norway., Mirlashari MR; Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, Oslo, 0450, Norway., Nissen-Meyer LS; Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, Oslo, 0450, Norway., Granerud BK; Institute of Clinical Medicine, University of Oslo, Oslo, 0315, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, 0424, Norway., Dyrhol-Riise AM; Institute of Clinical Medicine, University of Oslo, Oslo, 0315, Norway.; Department of Infectious Diseases, Oslo University Hospital, Oslo, 0424, Norway., Tonby K; Institute of Clinical Medicine, University of Oslo, Oslo, 0315, Norway.; Department of Infectious Diseases, Oslo University Hospital, Oslo, 0424, Norway., Holten AR; Institute of Clinical Medicine, University of Oslo, Oslo, 0315, Norway.; Department of Acute Medicine, Oslo University Hospital, Oslo, 0424, Norway., Heggelund L; Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, 3004, Norway.; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, 5009, Norway., Müller KE; Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, 3004, Norway.; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, 5009, Norway., Tveita A; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, 0424, Norway.; Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, 1346, Norway., Bøe S; Department of Anesthesiology and Intensive Care, Hammerfest County Hospital, Hammerfest, 9601, Norway., Fagerhol MK; Institute of Clinical Medicine, University of Oslo, Oslo, 0315, Norway.; Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, Oslo, 0450, Norway., Hetland G; Institute of Clinical Medicine, University of Oslo, Oslo, 0315, Norway.; Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, Oslo, 0450, Norway., Holter JC; Institute of Clinical Medicine, University of Oslo, Oslo, 0315, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, 0424, Norway.
Corporate Authors: Norwegian SARS-CoV-2 study group
Source: BMC infectious diseases [BMC Infect Dis] 2026 Mar 02; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 02.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2334
DOI:10.1186/s12879-026-12939-x